Immuron Ltd (IMRN)
2.52
+0.02
(+0.80%)
USD |
NASDAQ |
Jun 26, 12:06
Immuron Accounts Payable (Quarterly): 1.134M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.134M |
December 31, 2023 | 1.134M |
June 30, 2023 | 0.5235M |
December 31, 2022 | 0.0828M |
December 31, 2022 | 0.0828M |
June 30, 2022 | 0.4959M |
December 31, 2021 | 0.5107M |
December 31, 2021 | 0.5107M |
June 30, 2021 | 0.5699M |
December 31, 2020 | 0.1831M |
December 31, 2020 | 0.1831M |
Date | Value |
---|---|
June 30, 2020 | 0.1083M |
December 31, 2019 | 0.8393M |
December 31, 2019 | 0.8393M |
June 30, 2019 | 0.5008M |
December 31, 2018 | 0.2842M |
December 31, 2018 | 0.2842M |
June 30, 2018 | 0.1594M |
December 31, 2017 | 0.8792M |
December 31, 2017 | 0.8792M |
June 30, 2017 | 0.5376M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.0828M
Minimum
Dec 2022
1.134M
Maximum
Dec 2023
0.5133M
Average
0.5107M
Median
Dec 2021
Accounts Payable (Quarterly) Benchmarks
Alterity Therapeutics Ltd | 1.788M |
Kazia Therapeutics Ltd | 0.7073M |
Immutep Ltd | 1.127M |
Opthea Ltd | 31.70M |
Mesoblast Ltd | 20.14M |